Síndrome dismórfico neonatal y síndrome de Ogilvie

Abstract

Non-invasive medical treatment solves most cases. Promising results have been achieved with neostigmine. In the event of no response to drug therapy, the next step is endoscopic treatment. Even with high recurrence this is preferred due to its lower level of complications in contrast to surgical decompression. Neonatal dysmorphic syndrome is often associated with disorders of the central nervous system. So far, there have been no reports on the incidence of this disease with Ogilvie syndrome, although 9% of cases have been described as associated with neurological events. Conservative management in this disease is the initial approach. Interventions should be reserved for when conservative treatment fails.

Caso clínico: Síndrome de Ogilvie.

“…El síndrome de Ogilvie fue descrito en 1948 por el doctor William Ogilvie [1] en laparotomías exploratorias de pacientes con masas retroperitoneales con invasión del plexo celíaco [2]. La fisiopatología aún no se ha identificado pero podría ser por una alteración motriz del colon.…”